BioNTech SE (BNTX) Total Non-Current Liabilities (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Total Non-Current Liabilities data on file, last reported at $724.2 million in Q4 2025.

• In Q4 2025, Total Non-Current Liabilities rose 13.82% year-over-year to $724.2 million; the TTM figure through Dec 2025 stood at $724.2 million (up 13.82% YoY), while the FY2025 annual figure was $702.9 million, up 10.47% from the prior year.
• Total Non-Current Liabilities retreated to $724.2 million in Q4 2025, from $749.7 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $1.5 billion in Q2 2025 and bottomed at $278.4 million in Q4 2022.
• A 5-year average of $639.9 million and a median of $620.8 million in 2021 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2021 — Total Non-Current Liabilities soared 237.3% — and 2022, when it plunged 53.47%.
• Year by year, Total Non-Current Liabilities stood at $521.1 million in 2021, then sank by 46.57% to $278.4 million in 2022, then surged by 166.6% to $742.3 million in 2023, then fell by 14.29% to $636.2 million in 2024, then gained by 13.82% to $724.2 million in 2025.
• The last three Total Non-Current Liabilities figures came in at $724.2 million (Q4 2025), $749.7 million (Q3 2025), and $1.5 billion (Q2 2025), per Business Quant data.

Peer Comparison